Upregulation of MicroRNA 18b Contributes to the Development of Colorectal Cancer by Inhibiting CDKN2B

REFERENCES

• Amin M, Lockhart AC. 2015. The potential role of immunotherapy to treat colorectal cancer. Expert Opin Investig Drugs 24:329–344. https://doi.org/10.1517/13543784.2015.985376.
   PubMed Web of Science ®Google Scholar
• Brenner H, Kloor M, Pox CP. 2014. Colorectal cancer. Lancet 383:1490–1502. https://doi.org/10.1016/S0140-6736(13)61649-9.
   PubMed Web of Science ®Google Scholar
• Macfarlane LA, Murphy PR. 2010. MicroRNA: biogenesis, function and role in cancer. Curr Genomics 11:537–561. https://doi.org/10.2174/138920210793175895.
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Goel A. 2014. An update on microRNAs as colorectal cancer biomarkers: where are we and what's next? Expert Rev Mol Diagn 14:999–1021. https://doi.org/10.1586/14737159.2014.946907.
   PubMed Web of Science ®Google Scholar
• Mendell JT. 2008. miRiad roles for the miR-17-92 cluster in development and disease. Cell 133:217–222. https://doi.org/10.1016/j.cell.2008.04.001.
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tamori A, Itami S, Tanahashi T, Toyoda H, Tanaka M, Wu W, Brojigin N, Kaneoka Y, Maeda A, Kumada T, Kawada N, Kubo S, Kuroda M. 2013. The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer 13:99. https://doi.org/10.1186/1471-2407-13-99.
   PubMed Web of Science ®Google Scholar
• Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, Wang Y. 2009. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24:652–657. https://doi.org/10.1111/j.1440-1746.2008.05666.x.
   PubMed Web of Science ®Google Scholar
• Yu X, Zhen Y, Yang H, Wang H, Zhou Y, Wang E, Marincola FM, Mai C, Chen Y, Wei H, Song Y, Lyu X, Ye Y, Cai L, Wu Q, Zhao M, Hua S, Fu Q, Zhang Y, Yao K, Liu Z, Li X, Fang W. 2013. Loss of connective tissue growth factor as an unfavorable prognosis factor activates miR-18b by PI3K/AKT/C-Jun and C-Myc and promotes cell growth in nasopharyngeal carcinoma. Cell Death Dis 4:e634. https://doi.org/10.1038/cddis.2013.153.
   Google Scholar
• Fonseca-Sanchez MA, Perez-Plasencia C, Fernandez-Retana J, Arechaga-Ocampo E, Marchat LA, Rodriguez-Cuevas S, Bautista-Pina V, Arellano-Anaya ZE, Flores-Perez A, Diaz-Chavez J, Lopez-Camarillo C. 2013. microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration. Oncol Rep 30:2399–2410. https://doi.org/10.3892/or.2013.2691.
   PubMed Web of Science ®Google Scholar
• Kim TH, Kim YK, Kwon Y, Heo JH, Kang H, Kim G, An HJ. 2010. Deregulation of miR-519a, 153, and 485-5p and its clinicopathological relevance in ovarian epithelial tumours. Histopathology 57:734–743. https://doi.org/10.1111/j.1365-2559.2010.03686.x.
   PubMedGoogle Scholar
• Dacic S, Kelly L, Shuai Y, Nikiforova MN. 2010. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol 23:1577–1582. https://doi.org/10.1038/modpathol.2010.152.
   PubMed Web of Science ®Google Scholar
• Cookson VJ, Bentley MA, Hogan BV, Horgan K, Hayward BE, Hazelwood LD, Hughes TA. 2012. Circulating microRNA profiles reflect the presence of breast tumours but not the profiles of microRNAs within the tumours. Cell Oncol 35:301–308. https://doi.org/10.1007/s13402-012-0089-1.
   PubMed Web of Science ®Google Scholar
• Azizian A, Kramer F, Jo P, Wolff HA, Beissbarth T, Skarupke R, Bernhardt M, Grade M, Ghadimi BM, Gaedcke J. 2015. Preoperative prediction of lymph node status by circulating mir-18b and mir-20a during chemoradiotherapy in patients with rectal cancer. World J Surg 39:2329–2335. https://doi.org/10.1007/s00268-015-3083-8.
   PubMed Web of Science ®Google Scholar
• Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gafa R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. 2012. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology 142:886–896. https://doi.org/10.1053/j.gastro.2011.12.047.
   PubMed Web of Science ®Google Scholar
• Qu LL, He L, Zhao X, Xu W. 2015. Downregulation of miR-518a-3p activates the NIK-dependent NF-kappaB pathway in colorectal cancer. Int J Mol Med 35:1266–1272. https://doi.org/10.3892/ijmm.2015.2145.
   PubMed Web of Science ®Google Scholar
• Ortega S, Malumbres M, Barbacid M. 2002. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602:73–87.
   PubMed Web of Science ®Google Scholar
• Birt DF, Phillips GJ. 2014. Diet, genes, and microbes: complexities of colon cancer prevention. Toxicol Pathol 42:182–188. https://doi.org/10.1177/0192623313506791.
   PubMed Web of Science ®Google Scholar
• Yin Y, Song M, Gu B, Qi X, Hu Y, Feng Y, Liu H, Zhou L, Bian Z, Zhang J, Zuo X, Huang Z. 2016. Systematic analysis of key miRNAs and related signaling pathways in colorectal tumorigenesis. Gene 578:177–184. https://doi.org/10.1016/j.gene.2015.12.015.
   PubMed Web of Science ®Google Scholar
• Basu RK, Wong HR, Krawczeski CD, Wheeler DS, Manning PB, Chawla LS, Devarajan P, Goldstein SL. 2014. Combining functional and tubular damage biomarkers improves diagnostic precision for acute kidney injury after cardiac surgery. J Am Coll Cardiol 64:2753–2762. https://doi.org/10.1016/j.jacc.2014.09.066.
   PubMed Web of Science ®Google Scholar
• Dar AA, Majid S, Rittsteuer C, de Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR, III, Kashani-Sabet M. 2013. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst 105:433–442. https://doi.org/10.1093/jnci/djt003.
   PubMedGoogle Scholar
• Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A, Croce N, Vandesompele J, Mestdagh P, Finazzi-Agro E, Levine AJ, Melino G, Bernardini S, Candi E. 2013. DNA methylation silences miR-132 in prostate cancer. Oncogene 32:127–134. https://doi.org/10.1038/onc.2012.14.
   PubMed Web of Science ®Google Scholar
• Wu JH, Wang YH, Wang W, Shen W, Sang YZ, Liu L, Chen CM. 2016. miR-18b suppresses high-glucose-induced proliferation in HRECs by targeting IGF-1/IGF1R signaling pathways. Int J Biochem Cell Biol 73:41–52. https://doi.org/10.1016/j.biocel.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y, Yamashita H. 2011. Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer. Breast Cancer Res Treat 130:331–339. https://doi.org/10.1007/s10549-011-1672-2.
   PubMed Web of Science ®Google Scholar
• Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M, Khankhanian P, Inza I, Lozano JA, Castillo-Trivino T, Asensio A, Olaskoaga J, de Munain AL. 2009. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 4:e6309. https://doi.org/10.1371/journal.pone.0006309.
   PubMed Web of Science ®Google Scholar
• Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ. 2007. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42:1137–1141. https://doi.org/10.1016/j.yjmcc.2007.04.004.
   PubMed Web of Science ®Google Scholar
• Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A. 2007. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a. Nature 448:943–946. https://doi.org/10.1038/nature06084.
   PubMed Web of Science ®Google Scholar
• Li J, Knobloch TJ, Poi MJ, Zhang Z, Davis AT, Muscarella P, Weghorst CM. 2014. Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells. Mol Carcinog 53:211–218. https://doi.org/10.1002/mc.21965.
   PubMedGoogle Scholar
• do Nascimento Borges B, Burbano RM, Harada ML. 2013. Analysis of the methylation patterns of the p16 INK4A, p15 INK4B, and APC genes in gastric adenocarcinoma patients from a Brazilian population. Tumour Biol 34:2127–2133. https://doi.org/10.1007/s13277-013-0742-y.
   PubMed Web of Science ®Google Scholar
• Li J, Bi L, Lin Y, Lu Z, Hou G. 2014. Clinicopathological significance and potential drug target of p15INK4B in multiple myeloma. Drug Des Devel Ther 8:2129–2136. https://doi.org/10.2147/DDDT.S71088.
   PubMed Web of Science ®Google Scholar
• Camacho CV, Mukherjee B, McEllin B, Ding LH, Hu B, Habib AA, Xie XJ, Nirodi CS, Saha D, Story MD, Balajee AS, Bachoo RM, Boothman DA, Burma S. 2010. Loss of p15/Ink4b accompanies tumorigenesis triggered by complex DNA double-strand breaks. Carcinogenesis 31:1889–1896. https://doi.org/10.1093/carcin/bgq153.
   PubMedGoogle Scholar
• Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562–578. https://doi.org/10.1038/nprot.2012.016.
   PubMed Web of Science ®Google Scholar
• Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105–1111. https://doi.org/10.1093/bioinformatics/btp120.
   PubMed Web of Science ®Google Scholar
• Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL. 2013. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14:R36. https://doi.org/10.1186/gb-2013-14-4-r36.
   PubMed Web of Science ®Google Scholar